Great Waters Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$376K Sell
1,436
-7
-0.5% -$1.79K 0.03% 90
2026
Q2
$363K Buy
1,443
+258
+22% +$55.5K 0.03% 90
2026
Q1
$258K Buy
1,185
+4
+0.3% +$887 0.03% 103
2025
Q4
$270K Buy
1,181
+5
+0.4% +$1.14K 0.03% 98
2025
Q3
$272K Sell
1,176
-6
-0.5% -$1.22K 0.03% 92
2025
Q2
$219K Buy
1,182
+6
+0.5% +$1.11K 0.03% 98
2025
Q1
$246K Sell
1,176
-11
-0.9% -$2.14K 0.03% 84
2024
Q4
$211K Sell
1,187
-74
-6% -$13.6K 0.03% 104
2024
Q3
$249K Sell
1,261
-7
-0.6% -$1.31K 0.03% 92
2024
Q2
$217K Buy
+1,268
New +$210K 0.03% 93

Other funds holding ABBV

Great Waters Wealth Management's ABBV Position: Q3 2026 in Review

Great Waters Wealth Management reduced its AbbVie (ABBV) stake by 0.49% in Q3 2026, selling an estimated $1.79K and leaving 1,436 shares worth $376K. The position accounts for 0.03% of the portfolio, ranked #90.

Great Waters Wealth Management first reported a position in ABBV in Q2 2024 and has held it in 10 quarters since. 541 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Great Waters Wealth Management held 1,436 shares of AbbVie worth $376K as of Q3 2026.
  • Great Waters Wealth Management sold 7 AbbVie shares in Q3 2026, an estimated $1.79K.
  • AbbVie made up 0.03% of Great Waters Wealth Management's portfolio in Q3 2026, its #90 holding.
  • Great Waters Wealth Management first reported a position in AbbVie in Q2 2024 and has held it in 10 quarters since.
  • 541 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Great Waters Wealth Management's 13F filing for Q3 2026, filed 7 Oct 2026.